+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 3 Actively Recruiting clinical trials

S

Actively Recruiting

Researchers are evaluating the effects of vicadrostat combined with empagliflozin in adults who have type 2 diabetes, high blood pressure, and established cardiovascular disease but no history of heart failure. This study aims to understand if this combination can reduce the risk of cardiovascular events compared to a placebo combined with empagliflozin. Participation is randomized and double-blinded to compare these treatments fairly. Participants are randomly assigned to one of two groups one takes vicadrostat plus empagliflozin, and the other takes placebo tablets that look like vicadrostat plus empagliflozin. They take one tablet daily for a period ranging from two and a half years up to four years and three months. All participants continue their regular medications for diabetes, hypertension, and cardiovascular disease alongside the study treatments. Throughout the study, participants attend regular visits where their health is carefully monitored. Doctors collect information about cardiovascular events and take blood samples. They also track any side effects and changes in blood pressure and kidney function. The main outcome is the time until the first cardiovascular death or heart failure event, observed over up to 51 months. Participants stay in the study for up to four years and three months with ongoing health assessments.

Age: 18Years +All GendersPhase 3
1142 locations
S

Actively Recruiting

Researchers are evaluating an upgraded formulation of Elemental 028 Extra, a nutritionally complete amino acid-based feed designed for patients with severe gastrointestinal tract impairments. This case study series focuses on assessing the acceptability, compliance, and gastrointestinal tolerance of the new formulation in both adult and pediatric patients who need an elemental diet due to conditions such as inflammatory bowel disease, short bowel syndrome, malabsorption, allergic diseases, and neurodegenerative disorders. Participants will receive either the powder or liquid versions of the upgraded Elemental 028 Extra feed, which contains increased energy, protein content, and micronutrients to better meet patient needs. The study includes a 1-day baseline period followed by a 28-day intervention period during which the feed is used as a sole source of nutrition. This research is conducted across multiple centers in the UK to meet regulatory requirements for acceptability studies. During the 29-day study, participants will be monitored for gastrointestinal tolerance, acceptability, compliance, and anthropometric measurements at both the start and end of the intervention. Data collection includes assessments of these outcomes to understand how well patients tolerate and adhere to the upgraded feed. The study does not include blinding and follows a protocol designed to ensure patient safety and accurate data on the nutritional supplements use.

Age: 3Years +All GendersPhase Not Applicable
1 location
S

Actively Recruiting

Researchers are evaluating whether a reformulated plant-protein dominant blend in four existing enteral tube feeds works as effectively as animal-protein dominant formulations in adults who receive tube feeding at home. This exploratory randomized controlled trial includes a 3-day baseline period followed by a 3-month intervention and longer follow-up periods of 6 and 12 months. The study focuses on gastrointestinal tolerance, compliance, acceptability, body measurements, nutrient intake, and physical function. During the initial 3-day baseline, participants continue their usual tube feeding as determined by their dietitian. After this, they are randomly assigned to receive either one or a combination of four plant-protein dominant feeds or animal-protein dominant feeds for 90 days. Each feed provides at least 500 ml per day, offering a minimum of 500 kcal. After the intervention, participants can choose to continue for a full 12-month follow-up with data collected at 6 and 12 months. Participants will be closely monitored throughout the study, with assessments of gastrointestinal tolerance, acceptability, compliance, nutritional intake, and various physical measures such as body weight, height, calf circumference, and muscle strength tests. These measures are taken from baseline through the intervention and follow-up periods. The research team will use these data to compare the effects of plant-protein versus animal-protein dominant feeds on long-term outcomes in community-based adults requiring enteral nutrition.

Age: 16Years +All GendersPhase Not Applicable
1 location